HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: A randomized clinical trial

Diabetes Care

Volumn 38, Issue 1, 2015, Pages 51-58

  Knowler, William C ^a   Edelstein, Sharon L ^b   Goldberg, Ronald B ^c   Ackermann, Ronald T ^d   Crandall, Jill P ^e   Florez, Jose C ^f   Fowler, Sarah E ^g   Herman, William H ^h   Horton, Edward S ⁱ   Kahn, Steven E ^j   Mather, Kieren J ^k   Nathan, David M ^f  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Biostatistics Center   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ JOSLIN DIABETES CENTER   (United States)

^j VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^k INDIANA UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; PLACEBO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; BODY MASS; DIABETES MELLITUS, TYPE 2; DOUBLE BLIND PROCEDURE; INCIDENCE; METABOLISM; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LIFE STYLE; MALE; METFORMIN; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84919999231     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0886     Document Type: Article

References (30)

1. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999; 22:623-634
2. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
3. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374: 1677-1686
4. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197
5. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
7. Pajunen P, Peltonen M, Eriksson JG, et al.; Finnish Diabetes Prevention Study. HbA(1c) in diagnosing and predicting type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabet Med 2011; 28:36-42
8. Saito T,WatanabeM,Nishida J, et al.; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: A randomized controlled trial. Arch Intern Med 2011;171: 1352-1360
9. Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerancedanalysis of the Indian Diabetes Prevention Programmes. Diabet Med 2012;29:94-98
10. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568
11. Kitabchi AE, Temprosa M, Knowler WC, et al.; Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005;54: 2404-2414
12. Hundal RS, Krssak M, Dufour S, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000;49: 2063-2069
13. McCance DR, Hanson RL, Charles M-A, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308:1323-1328
14. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE; Australian Diabetes Obesity and Lifestyle Study Group. Longitudinal association of glucose metabolism with retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008;31:1349-1354
15. Colagiuri S, Lee CMY, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K; DETECT-2 Collaboration Writing Group. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011;34:145-150
16. Selvin E, Ning Y, Steffes MW, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011;60:298-305
17. Haffner S, Temprosa M, Crandall J, et al.; Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005;54:1566-1572
18. Orchard TJ, Temprosa M, Barrett-Connor E, et al.; Diabetes Prevention Program Outcomes Study Research Group. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPP Outcomes Study. DiabetMed 2013;30:46-55
19. Hivert MF, Jablonski KA, Perreault L, et al.; DIAGRAM Consortium; Diabetes Prevention Program Research Group. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes 2011;60:1340-1348
20. Franks PW, Jablonski KA, Delahanty LM, et al.; Diabetes Prevention Program Research Group. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 2008;51:2214-2223
21. Pan Q, Delahanty LM, Jablonski KA, et al.; Diabetes Prevention Program Research Group. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the Diabetes Prevention Program. Obesity (Silver Spring) 2013;21:E520-E526
22. Crandall J, Schade D, Ma Y, et al.; Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006; 61:1075-1081
23. Herman WH, Ma Y, Uwaifo G, et al.; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457
24. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-777
25. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: A cross-sectionalanalysis of community-based data. Ann Intern Med 2011;154:303-309
26. Tsugawa Y, Mukamal KJ, Davis RB, Taylor WC, Wee CC. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med 2012;157:153-159
27. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
28. Maruthur NM, Kao WHL, Clark JM, et al. Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes 2011;60:2434-2438
29. Grimsby JL, Porneala BC, Vassy JL, et al.; MAGIC Investigators. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: The third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet 2012;13:30
30. Knowler WC. Prevention of type 2 diabetes: Comment on "Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels." Arch Intern Med 2011;171:1361-1362